Despite signs of infection—including taste loss, dry mouth and mucosal lesions such as
ulcerations, enanthema and macules—the involvement of the oral cavity in coronavirus disease …

Nonalcoholic fatty liver disease (NAFLD) is characterized by hepatic steatosis in the
absence of a history of significant alcohol use or other known liver disease. Nonalcoholic …

… The liver biopsy slides of these 859 patients were shipped for central pathology reading and
scoring to Dr David Kleiner at the National Cancer Institute, who was unaware of the patients…

Background The bile acid derivative 6-ethylchenodeoxycholic acid (obeticholic acid) is a
potent activator of the farnesoid X nuclear receptor that reduces liver fat and fibrosis in animal …

Liver cancer has the second highest worldwide cancer mortality rate and has limited
therapeutic options. We analyzed 363 hepatocellular carcinoma (HCC) cases by whole-exome …

Fatty liver associated with metabolic dysfunction is common, affects a quarter of the population,
and has no approved drug therapy. Although pharmacotherapies are in development, …

Coronavirus disease 2019 (COVID-19) is known to cause multi-organ dysfunction 1 , 2 – 3
during acute infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), …

AASLD Practice Guidance on the clinical assessment and manag... : Hepatology AASLD
Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver …

Background Nonalcoholic steatohepatitis is a common liver disease that can progress to
cirrhosis. Currently, there is no established treatment for this disease. Methods We randomly …

Background The prognoses with respect to mortality and hepatic and nonhepatic outcomes
across the histologic spectrum of nonalcoholic fatty liver disease (NAFLD) are not well …